Price (delayed)
$167.29
Market cap
$295.51B
P/E Ratio
61.28
Dividend/share
$6.06
EPS
$2.73
Enterprise value
$342.08B
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. On October 19, 2011, Abbott Laboratories announced its plan to separate
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.